Safety of enzyme replacement therapy for mucopolysaccharidosis II

被引：0
|
作者：
Almeida, Paulo H. R. F. [1 ,2 ]
de Lemos, Livia L. P. [1 ,2 ]
Alvares, Juliana [1 ,2 ]
Godman, Brian [3 ,4 ,5 ]
Bennie, Marion [3 ]
Acurcio, Francisco De A. [1 ,2 ]
Guerra Junior, Augusto A. [1 ,2 ]
机构：
[1] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[2] SUS Collaborating Ctr Technol Assessment & Excell, Belo Horizonte, MG, Brazil
[3] Univ Strathclyde, Glasgow, Lanark, Scotland
[4] Karolinska Inst, Stockholm, Sweden
[5] Univ Liverpool, Management Sch, Liverpool, Merseyside, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
479
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [31] Mucopolysaccharidosis type II (MPS II): Evaluate of food intakes in patients on enzyme replacement therapy
    Oliveira, R. B.
    Frangipani, B. J.
    Lauandos, J. R.
    Micheletti, C.
    Silveira, M. T.
    Vertemati, T.
    Martins, A. M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 100 - 100
  • [32] Enzyme replacement therapy for mucopolysaccharidosis type II: Experience from a Brazilian reference center
    Curiati, Marco A.
    Mendes, Carmen Silvia C.
    Rand, Maret H.
    Canossa, Sueli
    Goncalves, Cintia M.
    Silva, Rosangela M.
    Silva, Jose
    Oliveira, Renata B.
    Kyosen, Sandra O.
    Aranda, Carolina S.
    Martins, Ana Maria
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S34 - S35
  • [33] Oxidative stress in patients with mucopolysaccharidosis type II before and during enzyme replacement therapy
    Filippon, Leticia
    Vanzin, Camila S.
    Biancini, Giovana B.
    Pereira, Izabela N.
    Manfredini, Vanusa
    Sitta, Angela
    Peralba, Maria do Carmo R.
    Schwartz, Ida V. D.
    Giugliani, Roberto
    Vargas, Carmen R.
    MOLECULAR GENETICS AND METABOLISM, 2011, 103 (02) : 121 - 127
  • [34] ENZYME REPLACEMENT THERAPY (ERT)RESULTS OF PATIENTS WITH MUCOPOLYSACCHARIDOSIS TYPE II (HUNTER SYNDROME)
    Unal, O.
    Dogru-Ersoz, D.
    Alehan, D.
    Saglam, M.
    Hismi, B.
    Dursun, A.
    Tokatli, A.
    Coskun, T.
    Sivri, H. S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S145 - S145
  • [35] Effect of enzyme replacement therapy on sleep-disordered breathing in type II mucopolysaccharidosis
    D'Cruz, OF
    Vaughn, B
    Muenzer, J
    ANNALS OF NEUROLOGY, 2003, 54 : S151 - S151
  • [36] Dermatological manifestations in patients with mucopolysaccharidosis Type II and changes after enzyme replacement therapy
    Ribeiro, E. M.
    Silva, C. A. B.
    Schwartz, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 : S144 - S144
  • [37] Natural history of valve disease in patients with mucopolysaccharidosis II and the impact of enzyme replacement therapy
    Kampmann, Christoph
    Lampe, Christina
    Wiethoff, Christiane M.
    Arash-Kaps, Laila
    Mengel, Eugen
    Reinke, Joerg
    Beck, Michael
    Hennermann, Julia B.
    Abu-Tair, Tariq
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (01)
  • [38] ANTI-IDURSULFASE ANTIBODY AND THE EFFICACY OF ENZYME REPLACEMENT THERAPY IN THE PATIENTS WITH MUCOPOLYSACCHARIDOSIS II
    Tanaka, A.
    Hamazaki, T.
    Sawada, T.
    Kadono, C.
    Kudo, S.
    Shintaku, H.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S84 - S84
  • [39] Enzyme replacement therapy for mucopolysaccharidosis type I in Japan
    Okuyama, T.
    Tanaka, T.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 119 - 119
  • [40] Pregnancy, enzyme replacement therapy and mucopolysaccharidosis: successful outcome
    Guffon, Nathalie
    Azzi, Denia
    Fouilhoux, Alain
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S53 - S53
12345